Home > Investing > J&J forecasts $2.5 billion in 2021 COVID-19 vaccine sales, sets lower production target
Investing

J&J forecasts $2.5 billion in 2021 COVID-19 vaccine sales, sets lower production target

Published by Wanda Rich

Posted on July 21, 2021

Featured image for article about Investing
Related Posts
Why Financial Advisors Are Rethinking Gold Allocations
Why Financial Advisors Are Rethinking Gold Allocations
From Opaque to Investable: Yaniv Bertele's Blueprint for Transparent Alternatives
From Opaque to Investable: Yaniv Bertele's Blueprint for Transparent Alternatives
Private Equity Needs AI Advocates
Private Equity Needs AI Advocates
Understanding the Global Impact of Rising Medical Insurance Premiums on the Middle Class
Understanding the Global Impact of Rising Medical Insurance Premiums on the Middle Class
The New Model Driving Creative Investment in University Innovation
The New Model Driving Creative Investment in University Innovation
The return of tangible assets in modern portfolios
The return of tangible assets in modern portfolios
Retro Bikes And Insurance: What You Should Know?
Retro Bikes And Insurance: What You Should Know?
Top Stocks Powering the AI Boom in 2025
Top Stocks Powering the AI Boom in 2025
How often should you update your estate plan? The events that demand a refresh
How often should you update your estate plan? The events that demand a refresh
Top 5 Mutual Funds in the UAE: Performance, Features, and How to Invest
Top 5 Mutual Funds in the UAE: Performance, Features, and How to Invest
How One Investor Learned to Find Value Through a Wider Lens
How One Investor Learned to Find Value Through a Wider Lens
Freedom Holding Corp’s Global Rise: Why Institutional Investors Are Betting Big
Freedom Holding Corp’s Global Rise: Why Institutional Investors Are Betting Big
;